Selection and Spread of Artemisinin-Resistant Alleles in Thailand Prior to the Global Artemisinin Resistance Containment Campaign

PLoS Pathogens

Volumn 11, Issue 4, 2015, Pages

  Talundzic, Eldin ^a,b   Okoth, Sheila Akinyi ^b   Congpuong, Kanungnit ^c,d   Plucinski, Mateusz M ^a   Morton, Lindsay ^a   Goldman, Ira F ^a   Kachur, Patrick S ^a   Wongsrichanalai, Chansuda ^e   Satimai, Wichai ^c   Barnwell, John W ^a   Udhayakumar, Venkatachalam ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d BansomdejchaoprayaRajabhat University   (Thailand)

^e Independent Scholar   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ANTIINFECTIVE AGENT; ARTEMISININ DERIVATIVE; BACTERIAL ANTIGEN; K ANTIGENS; MEMBRANE ANTIGEN;

ALLELE; ARTICLE; DISEASE CONTROL; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG RESISTANCE; GENE MUTATION; GENETIC DISTANCE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHY; MALARIA; PLASMODIUM FALCIPARUM; PREVALENCE; THAILAND; ANTIBIOTIC RESISTANCE; EPIDEMIOLOGICAL MONITORING; GENETICS; HAZARDOUS WASTE; HUMAN; MALARIA, FALCIPARUM; MOLECULAR GENETICS; MUTATION; POLYMERASE CHAIN REACTION; PROCEDURES;

PLASMODIUM FALCIPARUM;

ALLELES; ANTI-INFECTIVE AGENTS; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; ARTEMISININS; CONTAINMENT OF BIOHAZARDS; DRUG RESISTANCE, MICROBIAL; EPIDEMIOLOGICAL MONITORING; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; MUTATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; THAILAND;

EID: 84929492770     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004789     Document Type: Article

References (34)

1. Noedl H., et al., Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med, 2008. 359(24): p. 2619–20. doi: 10.1056/NEJMc0805011 19064625
2. Vijaykadga S., et al., In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health, 2006. 11(2): p. 211–9. 16451346
3. Wongsrichanalai C., et al., Epidemiology of drug-resistant malaria. Lancet Infect Dis, 2002. 2(4): p. 209–18. 11937421
4. Wootton J.C., et al., Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature, 2002. 418(6895): p. 320–3. 12124623
5. Satimai W., et al., Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia. Malar J, 2012. 11: p. 300. 22929621
6. Alker A.P., et al., Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg, 2007. 76(4): p. 641–7. 17426163
7. Phyo A.P., et al., Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet, 2012. 379(9830): p. 1960–6. doi: 10.1016/S0140-6736(12)60484-X 22484134
8. Dondorp A.M., et al., Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med, 2009. 361(5): p. 455–67. doi: 10.1056/NEJMoa0808859 19641202
9. Amaratunga C., et al., Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis, 2012. 12(11): p. 851–8. doi: 10.1016/S1473-3099(12)70181-0 22940027
10. Carrara V.I., et al., Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999–2011: an observational study. PLoS Med, 2013. 10(3): p. e1001398. doi: 10.1371/journal.pmed.1001398 23472056
11. Kyaw M.P., et al., Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One, 2013. 8(3): p. e57689. doi: 10.1371/journal.pone.0057689 23520478
12. Takala-Harrison S., et al., Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A, 2013. 110(1): p. 240–5. doi: 10.1073/pnas.1211205110 23248304
13. Takala-Harrison S., et al., Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia. J Infect Dis, 2014. 211(5):670–9. doi: 10.1093/infdis/jiu491 25180241
14. WHO, Strategic Plan to Strengthen Malaria Control and Elimination in the Greater Mekong Sub region: 2010–2014. 2010: The World Health Organizaiton. Geneva.
15. Khamsiriwatchara A., et al., Artemisinin resistance containment project in Thailand. (I): Implementation of electronic-based malaria information system for early case detection and individual case management in provinces along the Thai-Cambodian border. Malar J, 2012. 11: p. 247. doi: 10.1186/1475-2875-11-247 22839508
16. WHO, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. 2008: World Health Organization. Geneva.
17. WHO, Global report on antimalarial drug efficacy and drug resistance: 2000–2010. 2010: World Health Organization. Geneva.
18. Cheeseman I.H., et al., A major genome region underlying artemisinin resistance in malaria. Science, 2012. 336(6077): p. 79–82. doi: 10.1126/science.1215966 22491853
19. Ariey F., et al., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature, 2014. 505(7481): p. 50–5. doi: 10.1038/nature12876 24352242
20. Ashley E.A., et al., Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med, 2014. 371(5): p. 411–23. doi: 10.1056/NEJMoa1314981 25075834
21. Miotto O., et al., Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet, 2015. 47(3):226–34 doi: 10.1038/ng.3189 25599401
22. Miotto O., et al., Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet, 2013. 45(6): p. 648–55. doi: 10.1038/ng.2624 23624527
23. Nyunt, M.H., et al., Molecular Assessment of Artemisinin Resistance Markers, Polymorphisms in the K13 Propeller, and a Multidrug-Resistance Gene in the Eastern and Western Border Areas of Myanmar. Clin Infect Dis, 2014. pii: ciu1160. [Epub ahead of print]
24. Tun, K.M., et al., Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis, 2015. pii: S1473-3099(15)70032-0.
25. Straimer J., et al., Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science, 2015. 347(6220): p. 428–31. doi: 10.1126/science.1260867 25502314
26. Pumpaibool T., et al., Genetic diversity and population structure of Plasmodium falciparum in Thailand, a low transmission country. Malar J, 2009. 8: p. 155. doi: 10.1186/1475-2875-8-155 19602241
27. Anderson T.J., Roper C., The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop, 2005. 94(3): p. 269–80. 15878153
28. Alam M.T., et al., Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand. Antimicrob Agents Chemother, 2011. 55(1): p. 155–64. doi: 10.1128/AAC.00691-10 20956597
29. WHO, Malaria in the greater Mekong subregion: regional and country profiles. 2008: The World Health Organization. Geneva.
30. Alam M.T., et al., Selective sweeps and genetic lineages of Plasmodium falciparum drug-resistant alleles in Ghana. J Infect Dis, 2011. 203(2): p. 220–7. doi: 10.1093/infdis/jiq038 21288822
31. Su X., et al., A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science, 1999. 286(5443): p. 1351–3. 10558988
32. Clark L.V., Jasieniuk M., POLYSAT: an R package for polyploid microsatellite analysis. Mol Ecol Resour, 2011. 11(3): p. 562–6. doi: 10.1111/j.1755-0998.2011.02985.x 21481215
33. Boc A., Diallo A.B., Makarenkov V., T-REX: a web server for inferring, validating and visualizing phylogenetic trees and networks. Nucleic Acids Res, 2012. 40(Web Server issue): p. W573–9. doi: 10.1093/nar/gks485 22675075
34. Hay S.I., et al., Developing global maps of the dominant anopheles vectors of human malaria. PLoS Med, 2010. 7(2): p. e1000209. doi: 10.1371/journal.pmed.1000209 20161718